Oscar Health, Inc.OSCRNYSE
Loading
EV/EBITDA Over TimeContracting
Percentile Rank17
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Percentile
P17
Within normal range
vs 3Y Ago
-2.8x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025-3.65-116.3%
202422.43+1141.4%
2023-2.15-267.0%
20221.29+336.3%
2021-0.55+97.2%
2020-19.55-624.1%
2019-2.70-